« Back
Home /
Enoxacin

Enoxacin

Manufacturer	MedChem Express
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Amount	100 mg
Item no.	HY-B0268-100mg
Targets	Bacterial; DNA/RNA Synthesis; MicroRNA; Antibiotic
CASRN	74011-58-8
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Enoxacin (AT 2266), a fluoroquinolone, interferes with DNA replication and inhibits bacterial DNA gyrase (IC50=126 µg/ml) and topoisomerase IV (IC50=26.5 µg/ml). Enoxacin is a miRNA processing activator and enhances siRNA-mediated mRNA degradation and promotes the biogenesis of endogenous miRNAs. Enoxacin has potent activities against gram-positive and -negative bacteria. Enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2 (TRBP)-mediated microRNA processing[1][2][3][4].
StorageTemperature	4°C (Powder, protect from light)
Shipping	Room Temperature
Manufacturers Applications	Neuroscience-Neuromodulation
MolecularWeight	320.32
Clinical_Information	Launched
Manufacturers Research_Area	Cancer; Infection
Solubility	10 mM in DMSO
Manufacturers Target	Antibiotic; Bacterial; DNA/RNA Synthesis; MicroRNA
Isoform	Quinolone
Pathway	Anti-infection; Cell Cycle/DNA Damage; Epigenetics
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-B0268-100mg-safety-datasheet.pdf